The efficiency of your vaccine candidate needs to be assessed in term of immunogenicity.
Your drug may involuntarily impact the immune system (induction of drug/carrier specific T-cell response or specific antibodies).
In order to address these 2 kind of issues, most of the time, you need first to isolate Peripheral Blood Mononuclear Cells (PBMCs) from whole blood samples.
PBMC isolation is performed using a standardized and optimized Ficoll gradient procedure. Critical technical steps are mastered and selected reagents are used to ensure you the best quality service.
You also want to be relieved from the following immunomonitoring on generated PBMCs samples: We ensure a wide range of standardized GLP compliant tests covering most of what could be required.
Texcell is your international CRO dedicated to providing GCLP/GLP/GMP biosafety and immunology services to support biopharmaceuticals’ development. We are committed to providing to our partners a flexible and customized service based on our 27 years of expertise.
Our facilities (3000 m²) are located in France and in the United States.
During 27 years, we have tested products now licensed by the FDA and the EMA (e.g. monoclonal antibodies, recombinant proteins, viral vaccines, human plasma products, biological APIs, gene therapy and cell therapy products).
Customer-oriented company, our scientific teams are at your full disposal, with PhD project managers and an R&D team on hand to optimize existing assays or develop new tests on request